Comparing Moderately and Ultra Hypofractionated Radiation Treatments for Post-operative Prostate Cancer

This is a multi-institution, randomized, non-inferiority Phase II trial comparing external beam radiotherapy delivered as 54 Gy in 20 fractions to prostate bed +/- 44 Gy in 20 fractions to pelvic lymph nodes delivered daily with external beam radiotherapy delivered as 30 Gy in 5 fractions to prostate bed +/- 25 Gy in 5 fractions to pelvic lymph nodes delivered on alternate days.

Trial Details

NCT ID
NCT06409910
Phase
PHASE2
Sponsor
University Health Network, Toronto
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Radiotherapy
Locations (sample)
  • London, Ontario, Canada|42.98339,-81.23304
  • Toronto, Ontario, Canada|43.65333,-79.38389
  • Toronto, Ontario, Canada|43.65333,-79.38389

Key Eligibility Criteria

  • Age \>/= 18 years
  • Able to provide informed consent
  • Histologic diagnosis of prostate adenocarcinoma
  • ECOG performance status 0-1

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →